San Francisco, Dec 07 The
global cell
surface marker detection market is expected to reach USD
6.49 billion by 2022, according to a new report by Grand View Research, Inc.
This growth in demand can be attributed to rise in incidence of oncology
diseases and other cell-associated disorders.
Rapid
introduction of advancements and automations in clinical laboratories is a key
factor affecting this industry. Incorporation of novel algorithms pertaining to
diagnosis and prognosis of chronic disorders is expected to fuel demand of this
market in the coming years.
Requirement
of solutions for data handling and interpretation of clinical conditions based
on obtained results are anticipated to enhance potential for R&D in this
sector, consequently driving market growth over the forecast period.
Browse full research report on Cell Surface Marker Detection Market:
www.grandviewresearch.com/industry-analysis/cell-surface-marker-detection-market
Further key findings from the report suggest:
- Flow
cytometry devices accounted for over 70% of the revenue generated in the
industry for 2014. This large share can be attributed to the growing
advancement in these instruments such as enhancement in efficiency and
resolution of fluorescence-based cytometric detectors. Furthermore,
presence of large product portfolio of different industry players
operating in cytometry is responsible for large market share of this
technique.
- Disease
diagnosis and identification accounted for over 50% of the revenue
generated in the market for 2014. High incidence rate of cell-associated
disorders and oncology diseases that need to be treated in order to curb
the mortality rate are the major drivers for growth of this segment.
- Determination
of novel drug targets and development of biopharmaceuticals for prognosis
of chronic diseases is anticipated to propel growth of research and drug
discovery sub-segment in the coming years. With expected development of
this segment, the sector will witness lucrative growth over the forecast
period.
- North America
accounted for the largest share of this sector for 2014, as there are is
significantly high number of research and development projects ongoing in
the region related to cytological investigation for proteomics, genomics,
and drug and vaccine development. Growing need for biopharmaceuticals is
also anticipated to fuel regional growth.
- North America
dominated the industry in 2014, with revenue estimated at USD 999.0
million. Presence of sophisticated healthcare infrastructure and favorable
government initiatives with respect to analytical techniques and their
applications for disease diagnosis and drug development are some key
factors likely to drive growth.
- Asia Pacific
is expected to witness lucrative growth from 2015 to 2022 due to the
presence of high-unmet medical needs coupled with rapidly rising
healthcare R&D investment and growing medical expenditures in emerging
economies of India and China
- Key
participants of the cell surface marker detection industry include Siemens
Healthcare, Nihon Kohden Corporation, Sartorius, Janssen Diagnostics Inc.,
Grifols SA, Thermo Fisher Scientific, BioRad Laboratories Inc., and F.
Hoffman La Roche Ltd.
- These
participants are involved in R&D for production of cell-specific
antibodies and collaborations with smaller entities operating in the
market as well as with academic research laboratories in order to maintain
their market position and enter the untapped market regions
Browse more reports of this category
by Grand View Research: www.grandviewresearch.com/industry/biotechnology
Grand
View Research has segmented cell surface marker detection market on the basis
of product, application, and region:
Cell
Surface Marker Detection Product Outlook (Market Revenue in USD Million, 2012 -
2022 )
- Flow
Cytometry
- Hematology
Analyzers
- Reagents
& Kits
Cell
Surface Marker Detection Application Outlook (Market Revenue in USD Million,
2012 - 2022 )
- Disease
Diagnosis & Identification
- Research
& Drug Discovery
- Others
Cell
Surface Marker Detection Regional Outlook (Market Revenue in USD Million, 2012
- 2022 )
- North America
- Europe
- Asia Pacific
- RoW
Browse press release of this report
by Grand View Research: www.grandviewresearch.com/press-release/global-cell-surface-marker-detection-market
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
For more information: www.grandviewresearch.com
No comments:
Post a Comment